72786-111 : Oxbryta 300 mg Oral Tablet, for Suspension


NDC: 72786-111
Labeler: Global Blood Therapeutics Inc.
Product Type: Human Prescription Drug
Drug Name:  Oxbryta
Dosage Form: Oral Tablet, for Suspension
Application #: NDA216157
Rev. Date: 


NDC Package Codes:

  • 72786-111-02: 60 TABLET, FOR SUSPENSION IN 1 BOTTLE, PLASTIC (72786‑111‑02)
  • 72786-111-03: 90 TABLET, FOR SUSPENSION IN 1 BOTTLE, PLASTIC (72786‑111‑03)

Active Ingredients:

  • Voxelotor

Dosage Strength:

  • 300 mg

Pharmaceutical Classes:

  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Hemoglobin S Polymerization Inhibitor [EPC]
  • Hemoglobin S Polymerization Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 72786-101 Oxbryta 500 mg Oral Tablet, Film Coated by Global Blood Therapeutics Inc.
  • 72786-102 Oxbryta 300 mg Oral Tablet, Film Coated by Global Blood Therapeutics Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72786-111 QR Code

< Prev: 72786-102Next: 72789-001 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.